메뉴 건너뛰기




Volumn 29, Issue 7, 2012, Pages 657-662

Heterogeneity of the tumor vasculature: The need for new tumor blood vessel type-specific targets

Author keywords

Ad VEGF A164; Aflibercept (VEGF Trap); Angiogenesis; Rapamycin; VPF VEGF A

Indexed keywords

VASCULOTROPIN A;

EID: 84868205253     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-012-9500-6     Document Type: Conference Paper
Times cited : (128)

References (31)
  • 1
    • 85013312416 scopus 로고
    • Tumor angiogenesis: Therapeutic implications
    • Folkman J (1971) Tumor angiogenesis: Therapeutic implications. N Engl J Med 285:1182-1186
    • (1971) N Engl J Med , vol.285 , pp. 1182-1186
    • Folkman, J.1
  • 2
    • 0036842215 scopus 로고    scopus 로고
    • Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy
    • Dvorak HF (2002) Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 20:4368-4380
    • (2002) J Clin Oncol , vol.20 , pp. 4368-4380
    • Dvorak, H.F.1
  • 3
    • 0036985699 scopus 로고    scopus 로고
    • Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implications
    • Ferrara N (2002) Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implications. Semin Oncol 29:10-14
    • (2002) Semin Oncol , vol.29 , pp. 10-14
    • Ferrara, N.1
  • 4
    • 33344474964 scopus 로고    scopus 로고
    • Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis
    • Shibuya M, Claesson-Welsh L (2006) Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 312:549-560
    • (2006) Exp Cell Res , vol.312 , pp. 549-560
    • Shibuya, M.1    Claesson-Welsh, L.2
  • 5
    • 0021111648 scopus 로고
    • Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
    • Senger DR, Galli SJ, Dvorak AM et al (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985
    • (1983) Science , vol.219 , pp. 983-985
    • Senger, D.R.1    Galli, S.J.2    Dvorak, A.M.3
  • 6
    • 3042548695 scopus 로고    scopus 로고
    • Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts
    • Inai T, Mancuso M, Hashizume H et al (2004) Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Path 165:35-52
    • (2004) Am J Path , vol.165 , pp. 35-52
    • Inai, T.1    Mancuso, M.2    Hashizume, H.3
  • 7
    • 0027197245 scopus 로고
    • Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
    • Kim KJ, Li B, Winer J et al (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841-844
    • (1993) Nature , vol.362 , pp. 841-844
    • Kim, K.J.1    Li, B.2    Winer, J.3
  • 8
    • 2542561964 scopus 로고    scopus 로고
    • Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
    • Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342
    • (2004) N Engl J Med , vol.350 , pp. 2335-2342
    • Hurwitz, H.1    Fehrenbacher, L.2    Novotny, W.3
  • 9
    • 41149138113 scopus 로고    scopus 로고
    • Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer
    • Jain RK (2008) Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer. Nat Rev Cancer 8:309-316
    • (2008) Nat Rev Cancer , vol.8 , pp. 309-316
    • Jain, R.K.1
  • 10
    • 79551559952 scopus 로고    scopus 로고
    • Bevacizumab treatment for solid tumors: Boon or bust?
    • Hayes DF (2011) Bevacizumab treatment for solid tumors: Boon or bust? J Am Med Assoc 305:506-508
    • (2011) J Am Med Assoc , vol.305 , pp. 506-508
    • Hayes, D.F.1
  • 14
    • 33947414473 scopus 로고    scopus 로고
    • VEGF-A and the induction of pathological angiogenesis
    • Nagy JA, Dvorak AM, Dvorak HF (2007) VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol 2: 251-275
    • (2007) Annu Rev Pathol , vol.2 , pp. 251-275
    • Nagy, J.A.1    Dvorak, A.M.2    Dvorak, H.F.3
  • 15
    • 17344390961 scopus 로고    scopus 로고
    • Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor
    • Pettersson A, Nagy JA, Brown LF et al (2000) Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest 80:99-115
    • (2000) Lab Invest , vol.80 , pp. 99-115
    • Pettersson, A.1    Nagy, J.A.2    Brown, L.F.3
  • 16
    • 0025994605 scopus 로고
    • First steps of tumor-related angiogenesis
    • Paku S, Paweletz N (1991) First steps of tumor-related angiogenesis. Lab Invest 65:334-346
    • (1991) Lab Invest , vol.65 , pp. 334-346
    • Paku, S.1    Paweletz, N.2
  • 17
    • 66249098899 scopus 로고    scopus 로고
    • VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation
    • Chang SH, Kanasaki K, Gocheva V et al (2009) VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation. Cancer Res 69:4537-4544
    • (2009) Cancer Res , vol.69 , pp. 4537-4544
    • Chang, S.H.1    Kanasaki, K.2    Gocheva, V.3
  • 18
    • 0024615091 scopus 로고
    • Distensibility of single capillaries and venules in the rat and frog mesentery
    • Swayne GT, Smaje LH, Bergel DH (1989) Distensibility of single capillaries and venules in the rat and frog mesentery. Int J Microcirc Clin Exp 8:25-42
    • (1989) Int J Microcirc Clin Exp , vol.8 , pp. 25-42
    • Swayne, G.T.1    Smaje, L.H.2    Bergel, D.H.3
  • 19
    • 0030045180 scopus 로고    scopus 로고
    • The vesiculo-vacuolar organelle (VVO): A distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation
    • Dvorak AM, Kohn S, Morgan ES et al (1996) The vesiculo-vacuolar organelle (VVO): A distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J Leukoc Biol 59:100-115
    • (1996) J Leukoc Biol , vol.59 , pp. 100-115
    • Dvorak, A.M.1    Kohn, S.2    Morgan, E.S.3
  • 20
    • 0029890824 scopus 로고    scopus 로고
    • Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin
    • Feng D, Nagy JA, Hipp J et al (1996) Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J Exp Med 183:1981-1986
    • (1996) J Exp Med , vol.183 , pp. 1981-1986
    • Feng, D.1    Nagy, J.A.2    Hipp, J.3
  • 21
    • 33746257413 scopus 로고    scopus 로고
    • Permeability properties of tumor surrogate blood vessels induced by VEGF-A
    • Nagy JA, Feng D, Vasile E et al (2006) Permeability properties of tumor surrogate blood vessels induced by VEGF-A. Lab Invest 86:767-780
    • (2006) Lab Invest , vol.86 , pp. 767-780
    • Nagy, J.A.1    Feng, D.2    Vasile, E.3
  • 22
    • 0035106147 scopus 로고    scopus 로고
    • Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery
    • Sundberg C, Nagy JA, Brown LF et al (2001) Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am J Pathol 158:1145-1160
    • (2001) Am J Pathol , vol.158 , pp. 1145-1160
    • Sundberg, C.1    Nagy, J.A.2    Brown, L.F.3
  • 23
    • 47949099628 scopus 로고    scopus 로고
    • Modes of resistance to antiangiogenic therapy
    • Bergers G, Hanahan D (2008) Modes of resistance to antiangiogenic therapy. Nat Rev Cancer 8:592-603
    • (2008) Nat Rev Cancer , vol.8 , pp. 592-603
    • Bergers, G.1    Hanahan, D.2
  • 24
    • 79957894276 scopus 로고    scopus 로고
    • Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
    • Carmeliet P, Jain RK (2011) Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discovery 10:417-427
    • (2011) Nat Rev Drug Discovery , vol.10 , pp. 417-427
    • Carmeliet, P.1    Jain, R.K.2
  • 25
    • 77951498489 scopus 로고    scopus 로고
    • Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis
    • Ferrara N (2010) Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis. Curr Opin Hematol 17:219-224
    • (2010) Curr Opin Hematol , vol.17 , pp. 219-224
    • Ferrara, N.1
  • 26
    • 0038476608 scopus 로고    scopus 로고
    • Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
    • Bergers G, Song S, Meyer-Morse N et al (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111:1287-1295
    • (2003) J Clin Invest , vol.111 , pp. 1287-1295
    • Bergers, G.1    Song, S.2    Meyer-Morse, N.3
  • 27
    • 84860130221 scopus 로고    scopus 로고
    • Anti-VEGFVEGFR therapy for cancer: Reassessing the target
    • Sitohy B, Nagy J, Dvorak H (2012) Anti-VEGF/VEGFR therapy for cancer: Reassessing the target. Cancer Res 72:1909-1914
    • (2012) Cancer Res , vol.72 , pp. 1909-1914
    • Sitohy, B.1    Nagy, J.2    Dvorak, H.3
  • 28
    • 81155132190 scopus 로고    scopus 로고
    • Tumor surrogate blood vessel subtypes exhibit differential susceptibility to anti-VEGF therapy
    • Sitohy B, Nagy J, Jaminet S-C et al (2011) Tumor surrogate blood vessel subtypes exhibit differential susceptibility to anti-VEGF therapy. Cancer Res 71:7021-7028
    • (2011) Cancer Res , vol.71 , pp. 7021-7028
    • Sitohy, B.1    Nagy, J.2    Jaminet, S.-C.3
  • 29
    • 68149169793 scopus 로고    scopus 로고
    • Rapamycin inhibition of the Akt/mTOR pathway blocks select stages of VEGF-A164-driven angiogenesis, in part by blocking S6Kinase
    • Xue Q, Nagy JA, Manseau EJ et al (2009) Rapamycin inhibition of the Akt/mTOR pathway blocks select stages of VEGF-A164-driven angiogenesis, in part by blocking S6Kinase. Arterioscler Thromb Vasc Biol 29:1172-1178
    • (2009) Arterioscler Thromb Vasc Biol , vol.29 , pp. 1172-1178
    • Xue, Q.1    Nagy, J.A.2    Manseau, E.J.3
  • 30
    • 0037143764 scopus 로고    scopus 로고
    • VEGF-Trap: A VEGF blocker with potent antitumor effects
    • Holash J, Davis S, Papadopoulos N et al (2002) VEGF-Trap: A VEGF blocker with potent antitumor effects. Proc Natl Acad Sci USA 99:11393-11398
    • (2002) Proc Natl Acad Sci USA , vol.99 , pp. 11393-11398
    • Holash, J.1    Davis, S.2    Papadopoulos, N.3
  • 31
    • 0034682892 scopus 로고    scopus 로고
    • Genes expressed in human tumor endothelium
    • St Croix B, Rago C, Velculescu V et al (2000) Genes expressed in human tumor endothelium. Science 289:1197-1202
    • (2000) Science , vol.289 , pp. 1197-1202
    • St Croix, B.1    Rago, C.2    Velculescu, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.